These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7865491)

  • 1. Effects of long-term treatment of captopril and enalapril on rat intestinal angiotensin converting enzyme specific activities.
    Song S; Yim KW; Kim NY; Yoon BC; Lee DH; Jung HC; Kim CY
    Korean J Intern Med; 1994 Jul; 9(2):67-71. PubMed ID: 7865491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution of angiotensin converting enzyme in the rat: effect of captopril treatment.
    Forslund T; Kouvonen I; Fyhrquist F
    Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):124-8. PubMed ID: 6324538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
    Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
    Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sheep testicular and epididymal angiotensin converting enzyme: inhibitions by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Biochem Mol Biol Int; 1997 Dec; 43(5):1063-70. PubMed ID: 9415815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of rat intestinal brush-border membrane angiotensin-converting enzyme in dietary protein digestion.
    Yoshioka M; Erickson RH; Woodley JF; Gulli R; Guan D; Kim YS
    Am J Physiol; 1987 Dec; 253(6 Pt 1):G781-6. PubMed ID: 2827504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis.
    Lieberman J; Zakria F
    Sarcoidosis; 1989 Sep; 6(2):118-23. PubMed ID: 2557660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter.
    Temple CS; Boyd CA
    Biochim Biophys Acta; 1998 Aug; 1373(1):277-81. PubMed ID: 9733984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of angiotensin-converting enzyme inhibitor on cefroxadine uptake by rabbit small intestinal brush border membrane vesicles.
    Kitagawa S; Takeda J; Kaseda Y; Sato S
    Biol Pharm Bull; 1997 Apr; 20(4):449-51. PubMed ID: 9145229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local corticosterone production and angiotensin-I converting enzyme shedding in a mouse model of intestinal inflammation.
    Salmenkari H; Issakainen T; Vapaatalo H; Korpela R
    World J Gastroenterol; 2015 Sep; 21(35):10072-9. PubMed ID: 26401072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine.
    Zhou XH; Li Wan Po A
    Biochem Pharmacol; 1994 Mar; 47(7):1121-6. PubMed ID: 8161340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digestion and assimilation of proline-containing peptides by rat intestinal brush border membrane carboxypeptidases. Role of the combined action of angiotensin-converting enzyme and carboxypeptidase P.
    Yoshioka M; Erickson RH; Kim YS
    J Clin Invest; 1988 Apr; 81(4):1090-5. PubMed ID: 2832443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G
    Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
    Lin CJ; Akarawut W; Smith DE
    Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.